The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands ; volume:110 ; number:1 ; day:9 ; month:8 ; year:2007 ; pages:189-197 ; date:7.2008
Breast cancer research and treatment ; 110, Heft 1 (9.8.2007), 189-197, 7.2008
- Urheber
-
Schaapveld, Michael
Visser, Otto
Louwman, W. J.
Willemse, Pax H. B.
Vries, Elisabeth G. E. de
Graaf, Winette T. A. van der
Otter, Renée
Coebergh, Jan Willem W.
Leeuwen, Flora E. van
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-007-9709-2
- URN
-
urn:nbn:de:101:1-2021081722453776160394
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schaapveld, Michael
- Visser, Otto
- Louwman, W. J.
- Willemse, Pax H. B.
- Vries, Elisabeth G. E. de
- Graaf, Winette T. A. van der
- Otter, Renée
- Coebergh, Jan Willem W.
- Leeuwen, Flora E. van
- SpringerLink (Online service)
Ähnliche Objekte (12)
Survival After Contralateral Axillary Metastasis in Breast Cancer
MRI evaluation of the contralateral breast in patients with recently diagnosed breast cancer
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
Axillary metastasis from occult breast cancer and synchronous contralateral breast cancer initially suspected to be cancer with contralateral axillary metastasis: a case report
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population
Prediction and clinical utility of a contralateral breast cancer risk model
A case of contralateral inguinal lymph node metastases from breast cancer
Survival After Contralateral Axillary Metastasis in Breast Cancer
MRI evaluation of the contralateral breast in patients with recently diagnosed breast cancer
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
Axillary metastasis from occult breast cancer and synchronous contralateral breast cancer initially suspected to be cancer with contralateral axillary metastasis: a case report
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population
Prediction and clinical utility of a contralateral breast cancer risk model
A case of contralateral inguinal lymph node metastases from breast cancer
Survival After Contralateral Axillary Metastasis in Breast Cancer
MRI evaluation of the contralateral breast in patients with recently diagnosed breast cancer
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
Axillary metastasis from occult breast cancer and synchronous contralateral breast cancer initially suspected to be cancer with contralateral axillary metastasis: a case report
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population
Prediction and clinical utility of a contralateral breast cancer risk model